Andrew Goodman
C.N.H. Long Professor of Microbial Pathogenesis and Director of Microbial Sciences Institute, Yale University
4th International Conference on Microbiome Engineering (ICME)
November 3, 2021 to November 5, 2021
The International Conference on Microbiome Engineering (ICME 2021) will bring together leaders and experts from academia and industry to discuss progress and needs to develop research, technology, and innovation. Microbial engineers at all levels, from trainees to established researchers, are welcomed to participate. Look forward to special sessions on tools and standards while networking with key players in this rapidly growing field.
I’m looking forward to reconnecting with the community members who’ve attended since the beginning and meeting new contributors. I’m particularly excited to continue the conversation about how to optimize cross-talk and collaboration between academia and industry.
The microbial engineering field sits at a unique intersection of academia and industry, with reciprocal relationships driving progress and innovation. ICME attendees will not only learn about the latest advances, but also explore new collaborative opportunities.
Featured Speakers
-
-
Ami Bhatt
Associate Professor, Stanford University -
Matthew Scarborough
Assistant Professor, University of Vermont -
Nathan Crook
Assistant Professor, North Carolina State University -
Christopher Mason
Professor, Weill Cornell Medicine -
Francisco Quintana
Professor, Brigham and Women’s Hospital -
Mark Charbonneau
Vice President, Solarea Bio -
Michelle O'Malley
Professor of Chemical Engineering, University of California, Santa Barbara -
Karsten Temme
Co-founder & CEO, Pivot Bio -
Ravi Sheth
Co-Founder, Kingdom Supercultures -
Stephanie Culler
Co-Founder and CEO, Persephone Biosciences -
Carlotta Ronda
Associate Research Scientist, Columbia University -
Cathryn Nagler
Bunning Family Professor, The University of Chicago -
Kerwyn Huang
Professor, Stanford University -
Cammie Lesser
Associate Professor, Harvard Medical School -
Will DeLoache
Co-Founder and Chief Scientific Officer, Novome Biotechnologies -
Matthew Henn
Executive Vice President and Chief Scientific Officer, Seres Therapeutics -
Denise Kelly
Investment Advisor, Seventure Partners -
Sloan Devlin
Assistant Professor , Harvard Medical School -
Ophelia Venturelli
Associate Professor of Biomedical Engineering, Duke University